trending Market Intelligence /marketintelligence/en/news-insights/trending/gvkRMv8bdLzzZIGdY5gXgw2 content esgSubNav
In This List

Emergent BioSolutions CEO to retire; replacement named

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Emergent BioSolutions CEO to retire; replacement named

Emergent BioSolutions Inc. said Daniel Abdun-Nabi is retiring as the company's CEO and board member.

Abdun-Nabi has been the company's CEO since April 2012.

Robert Kramer, the company's current president and COO, will replace Abdun-Nabi. Effective April 1, Kramer will assume the president and CEO roles. He will also assume Abdun-Nabi's board seat.

Gaithersburg, Md.-based Emergent BioSolutions is a life sciences company developing specialty products to address public health threats.